XF Drug Platform
Small molecule drug platform rapidly bactericidal with unique mechanisms of action
A platform of porphyrin molecules with antimicrobial activity intended for topical application for the treatment or prevention of infection
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action.
- Infection prevention
- Antimicrobial compounds
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Market entry
- Marketed product
- Joint Venture
Infectious disease area:
Co-development, licensing, and outsourcing are all parts of the Destiny pharma business model.
Destiny Pharma plc is a clinical stage, virtual biotech company